Entities / Company
Cyclacel.
company in Berkeley Heights, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
MarketBeat reported consensus rating for Cyclacel.Some support1 report
-
Cyclacel must file an amendment with the Secretary of State regarding its corporate status in Delaware.Some support2 reports
-
Cyclacel shares began trading on the Nasdaq Capital Market on July 3, 2025.Speculative1 report
-
Cyclacel is highlighting research into Fibrolamellar Cancer (FLC), noting that FLC is frequently misdiagnosed as Hepatocellular Carcinoma (HCC).Speculative1 report
-
Cyclacel entered into an amendment with Fitters Diversified Berhad, maintaining Fitters Sdn. Bhd. as a wholly-owned subsidiary.Speculative1 report
-
Cyclacel highlighted a study originating from Kuala Lumpur, Malaysia.Some support2 reports
-
Cyclacel reported its financial results in Kuala Lumpur, Malaysia.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Cyclacel this week
News at the entities that move Cyclacel most-
MarketBeat Mentioned togetherMarketBeat released analyst recommendations for small-cap communication services companies Optimum Communications and Criteo.Moves Cyclacel
-
Malaysia Shared contextThe government led by Prabowo Subianto addresses forest fires polluting the air, coinciding with student protests in Bandung.Moves Cyclacel
Connections
The 2 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
MarketBeat Mentioned together
MarketBeat publishes consensus ratings and market coverage regarding Cyclacel.
-
Malaysia Shared context
Cyclacel conducts its operations and reports financial results within the geographical context of Malaysia.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
1 eventJuly 2026
1 eventShow 1 earlier month
June 2026
6 events- Cyclacel must file an amendment with the Secretary of State regarding its corporate status in Delaware.
- Cyclacel shares began trading on the Nasdaq Capital Market on July 3, 2025.
- Cyclacel is highlighting research into Fibrolamellar Cancer (FLC), noting that FLC is frequently misdiagnosed as Hepatocellular Carcinoma (HCC).
- Cyclacel entered into an amendment with Fitters Diversified Berhad, maintaining Fitters Sdn. Bhd. as a wholly-owned subsidiary.
- Cyclacel highlighted a study originating from Kuala Lumpur, Malaysia.
- Cyclacel reported its financial results in Kuala Lumpur, Malaysia.